Deciphering Disruption: Inside Cathie Wood's Latest Plays Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies. MarketBeat · Nov 16, 2024
Stocks Settle Sharply Lower on the Outlook for Slower Fed Rate Cuts The S&P 500 Index ($SPX ) (SPY ) Friday closed down -1.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.40%. Stocks retreated Friday, with the S&P 500 and Nasdaq 100 falling to 1-1/2 week... Barchart · Nov 15, 2024
Stocks Tumble as Hawkish Fed and Strong US Economic News Boosts Bond Yields The S&P 500 Index ($SPX ) (SPY ) today is down -1.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.03%. Stocks today extended Thursday’s decline, with the S&P 500 and the Dow Jones Industrials... Barchart · Nov 15, 2024
Pharma shares hit as Trump picks RFK Jr to lead health department Choice of vaccine critic knocks some of world’s biggest drugmakers including Moderna, AstraZeneca and GSK The Guardian - UK · Nov 15, 2024
Moderna Stock Outlook: Is Wall Street Bullish or Bearish? Moderna has underperformed the broader market and its peers over the past year, and Wall Street analysts are cautious about the stock’s prospects. Barchart · Nov 12, 2024
Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread The Independent UK · Nov 7, 2024
Option Volatility And Earnings Report For November 4 - 8 We have some important companies with Palantir, Super Micro computer, Block, Moderna, Qualcomm, Arista Networks, Gilead Sciences and Airbnb all set to report. Barchart · Nov 4, 2024
Older adults should get 2 doses of the updated COVID shot, CDC says The 2024-2025 COVID-19 vaccines are available, and the CDC recommends that certain groups get two doses, spaced six months apart. LiveScience · Oct 25, 2024
Norovirus vaccine: How does the trial work, when could it be available and what will it mean for the NHS? Could the new ‘winter vomiting bug’ vaccine save the NHS in future winters? The Independent UK · Oct 22, 2024
Doctors trial world’s first mRNA vaccine against vomiting bug norovirus Jab could bring huge health and economic benefits as virus often spreads very rapidly and can be serious The Guardian - UK · Oct 22, 2024
World-first vaccine for vomiting bug norovirus trialled in the UK The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack. The Independent UK · Oct 22, 2024
World’s first vaccine for winter vomiting bug norovirus to be trialled in UK Final phase of vaccine trial to start soon using the same technology as Covid-19 jabs The Independent UK · Oct 22, 2024
Earnings Preview: What to Expect From Moderna's Report Moderna is all set to release its fiscal third-quarter earnings next month, and analysts project its loss to rise in double digits. Barchart · Oct 22, 2024
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history. The Conversation · Oct 7, 2024
The Independent UK · Sep 25, 2024 It's time to roll up sleeves for new COVID, flu shots Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines
Fortune · Sep 18, 2024 Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.
The Independent UK · Sep 12, 2024 Cancer vaccine breakthrough as tests show positive results on patients with tumours The jab, known as mRNA-4359, is developed by Moderna
Kiplinger · Sep 12, 2024 Stock Market Today: Stocks Rise in Choppy Day for Markets Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.
Kiplinger · Sep 12, 2024 Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.
Barchart · Sep 11, 2024 Is Moderna Stock Underperforming the Nasdaq? While Moderna has underperformed the broader Nasdaq index in 2024, analysts are reasonably bullish about the stock's potential.
Barchart · Sep 9, 2024 Stocks Finish Higher on Support From Chip Stock Rebound The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.30%. Stocks on Monday posted moderate gains on some dip buying following last Friday’s sharp...
The Conversation · Sep 9, 2024 New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.
Barchart · Sep 9, 2024 Stocks Climb on Strength in Chip Stocks The S&P 500 Index ($SPX ) (SPY ) today is up +0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off on some...
Barchart · Sep 9, 2024 Stocks Move Higher on Strength in Chip Stocks and Positive Corporate News The S&P 500 Index ($SPX ) (SPY ) today is up +0.85%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.11%. Stocks today are moderately higher, recovering some of last Friday’s sharp sell-off as chip...
International Business Times · Sep 4, 2024 Moderna MRNA Mpox Vaccine Shows Promise In Animal Study An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease symptoms and duration, according to an animal study published in the journal Cell on Wednesday.